Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice

The management of patients with myelofibrosis (MF) has dramatically changed since the introduction of ruxolitinib as a tailored treatment strategy. However, the perceptions about the use of this drug in clinical practice remain, at times, a matter of discussion. We conducted a survey about the diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Breccia, Massimo, Baratè, Claudia, Benevolo, Giulia, Bonifacio, Massimiliano, Elli, Elena Maria, Guglielmelli, Paola, Maffioli, Margherita, Malato, Alessandra, Mendicino, Francesco, Palumbo, Giuseppe Alberto, Pugliese, Novella, Rossi, Elena, Rumi, Elisa, Sant’Antonio, Emanuela, Ricco, Alessandra, Tiribelli, Mario, Palandri, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944647/
https://www.ncbi.nlm.nih.gov/pubmed/31832751
http://dx.doi.org/10.1007/s00277-019-03847-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944647/
https://www.ncbi.nlm.nih.gov/pubmed/31832751
http://dx.doi.org/10.1007/s00277-019-03847-z

Ejemplares similares